By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for ETF ALPS Medical Breakthroughs ETF

ALPS Medical Breakthroughs ETF (SBIO)

AMEX Currency in USD
$201.00
+$2.12
+1.07%
Last Update: 18 Jul 2026, 10:13
$201.65m
Assets Under Management
50.00%
Expense Ratio
Forward Dividend Yield
$150.28-$259.90
52 Week Range

SBIO Price Chart

Explore ALPS Medical Breakthroughs ETF interactive price chart. Choose custom timeframes to analyze SBIO price movements and trends.

SBIO ETF Profile

Key details and information about ALPS Medical Breakthroughs ETF (SBIO).

Sector Focus

Financial Services

Industry

Asset Management

Inception Date

30 Dec 2014

Country

US

Description

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

SBIO ETF Performance

View SBIO with an interactive analytics dashboard featuring price and candlestick charts, key metrics, holdings breakdowns, and dividend yield history. Open the template in Insights to customize and save it.

Explore Related ETFs

Discover other exchange-traded funds. Select a symbol to access its full profile.

Discover More
Command Palette
Search for a command to run